SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-12-225450
Filing Date
2012-05-10
Accepted
2012-05-10 16:03:11
Documents
11
Period of Report
2012-03-31
Filing Date Changed
2012-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d332603d10q.htm 10-Q 497939
2 SEPARATION AGREEMENT d332603dex101.htm EX-10.1 25063
3 RULE 13A-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER d332603dex311.htm EX-31.1 7565
4 RULE 13A-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER d332603dex312.htm EX-31.2 7806
5 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d332603dex321.htm EX-32.1 3878
6 SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER d332603dex322.htm EX-32.2 3865
  Complete submission text file 0001193125-12-225450.txt   5548852

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT scln-20120331.xml EX-101.INS 1342315
8 XBRL TAXONOMY EXTENSION SCHEMA scln-20120331.xsd EX-101.SCH 14475
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scln-20120331_cal.xml EX-101.CAL 36709
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scln-20120331_lab.xml EX-101.LAB 123192
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scln-20120331_pre.xml EX-101.PRE 74889
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19825 | Film No.: 12830223
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1